WARFARIN Flashcards
Warfarin - what type of medication is this?
Anticoagulant
Warfarin - indications
Treatment and prevention of recurrence of Venous thromboembolism (VTE) Initial concomitant (alongside, combined) therapy of warfarin with heparin required; alternatively DOACs can be used
To prevent arterial embolism in patients with atrial fibrillation (AF) or prosthetic heart valves
For non-valvular AF, DOACs are alternatives
For prosthetic heart valves, treatment is short term (after tissue valve replacement) and life-long (after mechanical valve replacement)
Warfarin - what is the alterative to warfarin in patients with non-valvular AF?
REMEMBER:
valvular AF = warfarin
(v next to w in alphabet)
DOACs
Warfarin - administration
Taken each day at same time (6pm)
Warfarin - MOA
1) inhibits vitamin K epoxide reductase
2) this inhibits hepatic production of vitamin K dependent coagulation factors (factors II, VII, IX and X and proteins C and S)
3) this makes your blood clot more slowly
remember
WaVER - warfarin inhibits vit k epoxide reductase
Warfarin - adverse effects
→ The main adverse effect of Warfarin is bleeding
→ Minor over use can increase the risk of bleeding from a minor trauma (e.g.- minor head injury) and in existing abnormalities (e.g.- peptic ulcers)
→ Severe over use can trigger spontaneous bleeding such as epistaxis or retroperitoneal haemorrhage
Warfarin - how can the adverse effects of warfarin reversed?
Adverse effect of warfarin can be reversed with phytomenadione (Vitamin K1) or dried prothrombin complex
Warfarin - contraindications (avoid entirely)
AVOID:
→ In patients at immediate risk of haemorrhage (including after trauma and in patients requiring surgery)
→ In first trimester of pregnancy
Why? Risk of teratogenicity (cardiac and cranial abnormalities)
→ Later in pregnancy
Why? Risk of peripartum haemorrhage
Warfarin - caution
CAUTION:
→ In patients with liver disease
Why? Less able to metabolise drug = increase risk of side effect
Warfarin - interaction
CAUTION with: → Cytochrome P450 (CYP) inhibitors Why? Decreases warfarin metabolism and increases bleeding risk Examples: Fluconazole Macrolides
→ CYP inducers Why? Increases warfarin metabolism and risk of clots Examples: Phenytoin Carbamazepine Rifampicin